🔬 R&D Lab to Commercial Production Guide
DPP-260 vs DPP-140
DPP-260 vs DPP-140
Blister Machine: Pilot Scale or Commercial Production?
A complete comparison between HIJ's DPP-260 (commercial production) and DPP-140 (pilot/R&D scale) blister packing machines — capacity, applications, GMP compliance, scale-up paths, and pricing decoded by HIJ engineers.
R&D to Commercial Scale-Up
WHO GMP / cGMP Certified
CE Marking Compliant
100+ Pharma Factories
DPP-260 & DPP-140 At a Glance
Quick-reference fact sheet for both models — manufactured by HIJ Machinery (Wenzhou), compliant with WHO GMP, cGMP 21 CFR, and CE standards.
⭐ Commercial Scale
DPP-260 Automatic Blister Packing Machine
High-speed pharmaceutical commercial production
- ManufacturerHIJ Machinery (Wenzhou)
- Forming Area260 × 150 mm
- Production SpeedUp to 6,000 blisters/hr
- Annual Capacity30-100M blisters/yr
- Films CompatiblePVC / PVDC / Alu-Alu (opt.)
- ComplianceWHO GMP / cGMP / 21 CFR Part 11
- Footprint (L×W×H)2,800 × 850 × 1,750 mm
- Weight~1,800 kg
- Price (FOB)USD 45,000 – 120,000
- Best ForCommercial pharma production
🔬 Pilot/R&D Scale
DPP-140 Small Blister Packing Machine
Compact pilot machine for R&D and small batches
- ManufacturerHIJ Machinery (Wenzhou)
- Forming Area140 × 80 mm
- Production Speed1,800-2,400 blisters/hr
- Annual Capacity5-10M blisters/yr
- Films CompatiblePVC / PVDC (thermoforming)
- ComplianceWHO GMP / cGMP / CE
- Footprint (L×W×H)1,800 × 600 × 1,500 mm
- Weight~600 kg
- Price (FOB)USD 18,000 – 45,000
- Best ForR&D, clinical trials, startups
DPP-260 vs DPP-140: Full Specification Comparison
Side-by-side technical comparison across 18 critical decision factors that R&D managers and pharmaceutical procurement teams evaluate.
| Specification | DPP-260 ⭐ | DPP-140 🔬 |
|---|---|---|
| Production Scale | Commercial production | Pilot / R&D / Clinical trials |
| Forming Area | 260 × 150 mm +86% | 140 × 80 mm |
| Forming Depth (Max) | 25 mm | 15 mm |
| Production Speed | Up to 6,000 blisters/hr 3× | 1,800-2,400 blisters/hr |
| Annual Capacity | 30-100M blisters/year | 5-10M blisters/year |
| Punching Frequency | 25-50 cycles/min | 15-25 cycles/min |
| Drive System | Servo motor + Precision PLC | Standard motor + PLC |
| Forming Method | Thermoforming + Cold form (opt.) | Thermoforming only |
| Touchscreen HMI | 10" Color HMI | 7" Color HMI |
| Material Waste (Setup) | Higher (commercial volumes) | Minimal R&D-Friendly |
| Format Changeover | 30-45 minutes | 15-20 minutes Fast |
| GMP Compliance | WHO GMP / cGMP / 21 CFR Part 11 | WHO GMP / cGMP |
| CE Marking | Yes | Yes |
| Validation Documents | DQ/IQ/OQ/PQ (full package) | DQ/IQ/OQ/PQ (full package) |
| Power Consumption | 5.5 kW | 2.2 kW |
| Air Consumption | 0.6 m³/min @ 0.6 MPa | 0.3 m³/min @ 0.6 MPa |
| Machine Dimensions (L×W×H) | 2,800 × 850 × 1,750 mm | 1,800 × 600 × 1,500 mm Compact |
| Machine Weight | ~1,800 kg | ~600 kg |
| Price Range (FOB Wenzhou) | USD 45,000 – 120,000 | USD 18,000 – 45,000 Lower CAPEX |
| Lead Time | 12-16 weeks | 8-12 weeks Faster |
| Recommended Buyer | Established pharma manufacturers | R&D labs, startups, clinical sites |
Which Model Is Right For You?
DPP-260 and DPP-140 serve fundamentally different production stages. The right choice depends on whether you're in R&D, clinical trials, or commercial manufacturing.
⭐ Choose DPP-260 If
You're in Commercial Production Mode
- Annual output target above 10 million blisters
- Established pharma factory with proven product line
- Multi-product commercial portfolio with regular SKUs
- Need to handle Alu-Alu cold form (optional config)
- Export to regulated markets (US/EU/MENA)
- cGMP / 21 CFR Part 11 audit compliance required
- Have dedicated production cleanroom space (≥30 m²)
- Production lines in India, Brazil, Southeast Asia
🔬 Choose DPP-140 If
You're in R&D, Pilot, or Startup Mode
- Annual output target under 10 million blisters
- R&D laboratory or clinical trial batch production
- Pharmaceutical startup with limited initial capital
- Need fast format changeover for multiple formulations
- Limited cleanroom space (10-20 m² available)
- Process development & technology transfer studies
- Clinical phase I-II trial supplies (50-500 units/batch)
- Academic research or formulation testing labs
The HIJ Scale-Up Path: From Lab to Commercial
How pharmaceutical manufacturers progress from DPP-140 (R&D) to DPP-260 (commercial production) — a proven 4-stage path used by 100+ HIJ clients globally.
1
DPP-140
Formulation R&D
Develop blister formula, test PVC/PVDC compatibility, optimize forming parameters in lab.
2
DPP-140
Clinical Trial Batches
Produce Phase I-III clinical supply batches (50-500 units), generate validation data.
3
DPP-140 → DPP-260
Technology Transfer
Scale up validated parameters to commercial line. HIJ provides full transfer documentation.
4
DPP-260
Commercial Launch
Full commercial production at 30-100M blisters/year, regulatory submission ready.
Application Scenarios: Where Each Model Excels
Both DPP-260 and DPP-140 are GMP-compliant blister machines, but each is engineered for a specific stage of pharmaceutical product lifecycle.
| Application | DPP-260 (Commercial) | DPP-140 (Pilot/R&D) |
|---|---|---|
| Formulation R&D | ⚠️ Overspec (material waste) | ✅ Recommended |
| Process Development | ⚠️ Costly setup runs | ✅ Recommended |
| Clinical Trial Phase I-II | ⚠️ Low utilization | ✅ Ideal (small batches) |
| Clinical Trial Phase III | ✅ Suitable (volume up) | ⚠️ Capacity limited |
| Technology Transfer | ✅ Target machine | ✅ Source machine |
| Commercial Production | ✅ Excellent (high speed) | ❌ Insufficient capacity |
| Niche/Orphan Drug Production | ⚠️ Overspec | ✅ Recommended |
| Contract Manufacturing (Small) | ⚠️ Need volume | ✅ Compatible |
| Contract Manufacturing (Large) | ✅ Recommended | ❌ Insufficient |
| Academic/University Research | ❌ Too large | ✅ Ideal |
| Startup Pharma (Initial) | ⚠️ High CAPEX | ✅ Affordable entry |
| Established Pharma (Scale) | ✅ Recommended | ⚠️ Auxiliary use only |
| Effervescent Tablets | ✅ Recommended (Alu-Alu) | ⚠️ PVDC limited |
| Moisture-Sensitive Drugs | ✅ Alu-Alu cold form option | ⚠️ PVDC barrier only |
| Standard Tablets/Capsules | ✅ Excellent (high-volume) | ✅ Excellent (small batch) |
Frequently Asked Questions
Common questions from R&D managers, startup founders, and procurement teams comparing DPP-260 (commercial) and DPP-140 (pilot/R&D) blister machines.
What is the main difference between DPP-260 and DPP-140 blister machines?
The DPP-260 is a commercial-scale automatic blister packing machine with 260mm forming area and up to 6,000 blisters/hour output. The DPP-140 is a compact pilot/R&D scale machine with 140mm forming area and 1,800-2,400 blisters/hour. DPP-260 suits high-volume commercial production, while DPP-140 is designed for R&D labs, clinical trial batches, and small pharma startups with limited initial capital.
Is DPP-140 suitable for commercial pharmaceutical production?
DPP-140 is best suited for small-batch commercial production under 10 million blisters per year, R&D pilot runs, clinical trial batches, and lab-scale formulation testing. For commercial production above 30 million blisters annually, DPP-260 is recommended for higher throughput, lower per-unit operating cost, and better changeover efficiency between SKUs.
Can I scale up from DPP-140 to DPP-260 later?
Yes. HIJ provides a clear scale-up path from DPP-140 (R&D) to DPP-260 (commercial production). Process parameters validated on DPP-140 can be transferred to DPP-260 with proper scale-up validation. HIJ engineers support technology transfer documentation, validation protocols (DQ/IQ/OQ/PQ), and side-by-side comparison studies for FDA/WHO GMP regulatory submissions.
What is the price difference between DPP-260 and DPP-140?
DPP-140 ranges from USD 18,000-45,000 (FOB Wenzhou), making it accessible for startups and R&D labs. DPP-260 ranges from USD 45,000-120,000 due to higher capacity, larger forming area, upgraded servo control, 21 CFR Part 11 compliance, and Alu-Alu cold form capability. The price gap reflects 3× higher production output and commercial-grade durability for 24/7 operation.
Are both DPP-260 and DPP-140 GMP compliant?
Yes. Both DPP-260 and DPP-140 from HIJ Machinery comply with WHO GMP, cGMP 21 CFR Parts 210/211, and CE Machinery Directive 2006/42/EC. Complete DQ/IQ/OQ/PQ validation documentation is included with both models. DPP-260 additionally supports 21 CFR Part 11 electronic records for FDA-regulated commercial production and audit trail requirements.
Which model is better for clinical trial batches?
DPP-140 is the preferred choice for clinical trial batches due to its smaller batch size, lower material waste during setup (15-20 min changeover), faster format changeover, and compact footprint suitable for cleanroom integration. DPP-140 typically processes 50-500 unit clinical batches efficiently without requiring large material commitments — ideal for Phase I-II clinical supply.
What is the footprint difference between DPP-260 and DPP-140?
DPP-140 has a compact footprint of approximately 1,800 × 600 × 1,500 mm and weighs 600 kg, ideal for limited cleanroom space (10-20 m²). DPP-260 measures 2,800 × 850 × 1,750 mm and weighs 1,800 kg, requiring dedicated production floor space (≥30 m²) with utilities. Cleanroom HVAC and isolator requirements differ significantly based on installation.
Which DPP model do startup pharma factories typically choose?
Startup pharmaceutical factories with limited initial capital typically begin with DPP-140 for R&D and small commercial batches, then upgrade to DPP-260 once revenue scales and demand exceeds 10 million blisters/year. Some startups skip DPP-140 and start with DPP-250 or DPP-260 if commercial demand is established from launch — a common strategy in India and Southeast Asia markets.
Can DPP-140 run continuously like DPP-260?
DPP-140 is designed for intermittent batch production typical of R&D and small commercial runs (4-8 hours/day). DPP-260 is engineered for continuous 24/7 commercial operation with heavy-duty components, redundant cooling, and predictive maintenance features. Running DPP-140 24/7 is possible but reduces equipment lifespan; DPP-260 is the right choice for high-uptime commercial demand.
What lead time and after-sales support does HIJ provide?
DPP-140 standard lead time is 8-12 weeks; DPP-260 is 12-16 weeks from order confirmation. Both include manufacturing, FAT (Factory Acceptance Testing), and pre-shipment inspection. HIJ offers global on-site installation, commissioning, operator training, and 12-month warranty in 30+ countries via WhatsApp (+86 13868822120) and email ([email protected]).
Ready to Choose Your DPP Model?
Whether you need a pilot machine for R&D or a commercial line for full-scale production, HIJ engineers will review your requirements and recommend the optimal model with detailed pricing within 24 hours. No obligation. No spam.
Explore Related Resources
Continue your research with these related HIJ blister packaging resources.
About This Comparison: The DPP-260 and DPP-140 are pharmaceutical blister packing machines manufactured by HIJ Machinery (Wenzhou), a Chinese pharmaceutical packaging machinery company specializing in blister packaging machines, capsule filling machines, cartoning machines, and complete pharmaceutical packaging turnkey lines. DPP-260 is engineered for commercial-scale production, while DPP-140 serves R&D laboratories, clinical trial sites, and small-batch pharmaceutical operations.
Compliance: Both models comply with WHO GMP TRS 961 Annex 6, cGMP 21 CFR Parts 210/211, and CE Machinery Directive 2006/42/EC. DPP-260 additionally supports 21 CFR Part 11 electronic records and audit trail requirements for FDA-regulated markets.
Author: This comparison is authored by Forester Xiang, founder and chief engineer of HIJ Machinery, with 20+ years of pharmaceutical machinery experience and audits at 100+ pharmaceutical facilities across 30+ countries including India, Bangladesh, Vietnam, Nigeria, Egypt, Brazil, Germany, and the United States.
Source: HIJ Machinery (Wenzhou)
Website: https://hijpackingmachine.com
This page: https://hijpackingmachine.com/dpp-260-vs-dpp-140-blister-machine/
Contact: [email protected] | WhatsApp: +86 13868822120
Last updated: January 2026